- Home
- NUS
as 07-26-2024 4:00pm EST
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | PROVO |
| Market Cap: | 671.0M | IPO Year: | 1996 |
| Target Price: | $20.83 | AVG Volume (30 days): | 649.1K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -0.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.74 - $30.22 | Next Earning Date: | 08-08-2024 |
| Revenue: | $1,904,975,000 | Revenue Growth: | -9.38% |
| Revenue Growth (this year): | -9.05% | Revenue Growth (next year): | 3.24% |
Stock Insider Trading Activity of Nu Skin Enterprises Inc. (NUS)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| LIPMAN ANDREW D | NUS | Director | May 28 '24 | Sell | $13.33 | 2,000 | $26,660.00 | 23,225 | SEC Form 4 |
| WOODBURY EDWINA D | NUS | Director | May 2 '24 | Sell | $12.02 | 1,693 | $20,349.86 | 18,095 | SEC Form 4 |
| LIPMAN ANDREW D | NUS | Director | Apr 25 '24 | Sell | $12.34 | 2,000 | $24,680.00 | 25,225 | SEC Form 4 |
| LIPMAN ANDREW D | NUS | Director | Mar 25 '24 | Sell | $12.32 | 2,000 | $24,640.00 | 27,225 | SEC Form 4 |
| LIPMAN ANDREW D | NUS | Director | Feb 26 '24 | Sell | $12.46 | 2,000 | $24,920.00 | 29,225 | SEC Form 4 |
| LIPMAN ANDREW D | NUS | Director | Jan 25 '24 | Sell | $18.55 | 2,000 | $37,100.00 | 31,225 | SEC Form 4 |
| LIPMAN ANDREW D | NUS | Director | Dec 26 '23 | Sell | $19.39 | 2,000 | $38,780.00 | 33,225 | SEC Form 4 |
| LIPMAN ANDREW D | NUS | Director | Nov 3 '23 | Sell | $17.68 | 15,400 | $272,272.00 | 37,225 | SEC Form 4 |
Latest Nu Skin Enterprises Inc. News
NUS Breaking Stock News: Dive into NUS Ticker-Specific Updates for Smart Investing
Business Wire
7 hours ago
Nu Skin Surpasses 850 Million Meals Purchased and Donated in its Fight Against Child Malnutrition
StockStory
17 hours ago
Reflecting On Personal Care Stocks’ Q1 Earnings: Nu Skin (NYSE:NUS)
Argus Research
3 days ago
NUS: Lowering target price to $8.00
Argus Research
10 days ago
NUS: Raising target price to $9.00
StockStory
11 days ago
Q1 Earnings Outperformers: USANA (NYSE:USNA) And The Rest Of The Personal Care Stocks
Argus Research
17 days ago
NUS: Lowering target price to $8.00
Zacks
17 days ago
Nu Skin (NUS) Navigates a Tough Landscape on Growth Strategies
Simply Wall St.
22 days ago
Nu Skin Enterprises, Inc. (NYSE:NUS) is largely controlled by institutional shareholders who own 80% of the company
Compare NUS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NUS Nu Skin Enterprises Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.